Literature DB >> 6819172

In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum.

B W Arbogast, G M Lee, T L Raymond.   

Abstract

Primary cultures of porcine aortic endothelial cells were used to detect injurious agents in diabetic rat serum. Media containing normal or diabetic serum (streptozotocin-induced) were incubated with subconfluent primary cultures of endothelial cells. Cells exposed to 17% diabetic serum were severely contracted and permeable to trypan blue after 18 h. Cultures in normal serum contained significantly more protein (P less than 0.005) than cultures in diabetic serum after 1 day. When normal and diabetic serum were mixed in different proportions and added to cells at 17% total serum concentration, a 50% reduction from growth in normal serum occurred at a ratio of 1 part diabetic serum to 9 parts normal serum. The toxicity of diabetic serum was not altered by heat inactivation. Administration of insulin to diabetic rats reversed both cytotoxicity and elevated triglyceride levels. Serum triglyceride levels were inversely correlated with endothelial cell growth (r = -0.878, P less than 0.001). In vitro addition of up to 1 U/ml insulin to cultures in diabetic serum did not alter toxicity. Ultracentrifugal flotation of diabetic serum demonstrated the toxic substance to be entirely localized in the very-low-density lipoprotein fraction (d less than 1.006 g/ml). A pool of d greater than 1.006 fractions from diabetic serum supported growth equivalent to normal serum. Diabetic serum contains a substance localized in the very-low-density lipoprotein fraction that is severely toxic to aortic endothelial cells in vitro. Very-low-density lipoprotein injury of endothelial cells may play an important role in the development of arterial vascular disease in insulin-dependent diabetes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819172     DOI: 10.2337/diab.31.7.593

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry.

Authors:  H A Multhaupt; M E Gåfvels; K Kariko; H Jin; C Arenas-Elliot; B I Goldman; J F Strauss; B Angelin; M J Warhol; K R McCrae
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

2.  Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60.

Authors:  M K Cathcart; G M Chisolm; A K McNally; D W Morel
Journal:  In Vitro Cell Dev Biol       Date:  1988-10

3.  Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells.

Authors:  S Aanderud; H Krane; A Nordøy
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

4.  Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.

Authors:  G Gamba; S B Solerte; G Grignani; L Pacchiarini; N Montani; E Ferrari
Journal:  Blut       Date:  1988-06

Review 5.  Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.

Authors:  Hadi A R Hadi; Cornelia S Carr; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2005

Review 6.  Endothelial dysfunction in diabetes mellitus.

Authors:  Hadi A R Hadi; Jassim Al Suwaidi
Journal:  Vasc Health Risk Manag       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.